Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Polyethylene Glycols administration & dosage"" wg kryterium: Temat


Wyświetlanie 1-9 z 9
Tytuł :
Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: A randomised phase 2 study
Index Terms :
Cancérologie
Adult
Aged
Aged, 80 and over
Breast Neoplasms -- drug therapy -- mortality -- secondary
Camptothecin -- administration & dosage -- adverse effects -- analogs & derivatives -- pharmacokinetics
Drug Administration Schedule
Europe
Female
Heterocyclic Compounds with 4 or More Rings -- administration & dosage -- adverse effects -- pharmacokinetics
Humans
Intention to Treat Analysis
Kaplan-Meier Estimate
Middle Aged
Polyethylene Glycols -- administration & dosage -- adverse effects -- pharmacokinetics
Time Factors
Topoisomerase I Inhibitors -- administration & dosage -- adverse effects -- pharmacokinetics
Treatment Outcome
United States
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168222">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168222
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.
Index Terms :
Cancérologie
Antineoplastic Agents -- therapeutic use
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Disease-Free Survival
Epidemiologic Methods
Female
Humans
Immunologic Factors -- administration & dosage
Interferon-alpha -- administration & dosage
Male
Melanoma -- drug therapy -- mortality -- pathology
Neoplasm Staging
Polyethylene Glycols -- administration & dosage
Predictive Value of Tests
Randomized Controlled Trials as Topic
Recombinant Proteins -- administration & dosage
Skin Neoplasms -- drug therapy -- mortality -- pathology
Ulcer -- pathology
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144357">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/144357
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial.
Index Terms :
Sciences bio-médicales et agricoles
Adolescent
Adult
Aged
Antiviral Agents -- administration & dosage -- adverse effects -- therapeutic use
Bilirubin -- analysis
Double-Blind Method
Drug Therapy, Combination
Female
Genotype
Hepacivirus -- drug effects
Hepatitis C -- drug therapy -- virology
Heterocyclic Compounds, 3-Ring -- administration & dosage -- adverse effects -- therapeutic use
Humans
Interferon-alpha -- administration & dosage -- therapeutic use
Male
Middle Aged
Polyethylene Glycols -- administration & dosage -- therapeutic use
Protease Inhibitors -- administration & dosage -- adverse effects -- therapeutic use
RNA, Viral -- blood
Recombinant Proteins -- administration & dosage -- therapeutic use
Ribavirin -- administration & dosage -- pharmacology -- therapeutic use
Sulfonamides -- administration & dosage -- adverse effects -- therapeutic use
Viral Load
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156145">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156145
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
Index Terms :
Sciences bio-médicales et agricoles
Adult
Antiviral Agents -- administration & dosage -- adverse effects
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Follow-Up Studies
Hepatitis C, Chronic -- drug therapy
Humans
Interferon-alpha -- administration & dosage -- adverse effects
Kidney Failure, Chronic -- therapy
Kidney Transplantation
Male
Middle Aged
Polyethylene Glycols -- administration & dosage -- adverse effects
Recombinant Proteins
Renal Dialysis
Ribavirin -- administration & dosage -- adverse effects
Time Factors
Treatment Outcome
Viral Load
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156140">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156140
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
Index Terms :
Sciences bio-médicales et agricoles
Antiviral Agents -- administration & dosage
Drug Therapy, Combination
Hepatitis C, Chronic -- drug therapy -- metabolism -- virology
Humans
Insulin Resistance
Interferon-alpha -- administration & dosage
Polyethylene Glycols -- administration & dosage
Ribavirin -- administration & dosage
Treatment Outcome
Viral Load
Antiviral therapy
Hepatitis C
HOMA-IR index
Insulin resistance
Meta-analysis
Sustained virological response
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156141">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156141
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
Tytuł :
Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin beta therapy.
Index Terms :
Sciences bio-médicales et agricoles
Sciences pharmaceutiques
Drug Monitoring -- methods
Erythrocyte Indices
Erythropoietin -- administration & dosage -- therapeutic use
Hematologic Tests -- instrumentation -- methods
Humans
Iron -- blood -- deficiency -- therapeutic use
Kidney Failure, Chronic -- blood
Polyethylene Glycols -- administration & dosage -- therapeutic use
Practice Guidelines as Topic
Prospective Studies
Recombinant Proteins
Renal Dialysis
info:eu-repo/semantics/article
info:ulb-repo/semantics/articlePeerReview
info:ulb-repo/semantics/openurl/article
URL :
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/163648">http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/163648
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL">http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
Zasób elektroniczny
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies